Farage Miranda A, Cambron Tom, Liu Kan-Zhi
Corporate Function R&D, The Procter & Gamble Company, Cincinnati, OH, USA.
Corporate Function R&D, The Procter & Gamble Company, Mason, OH, USA.
Clin Med Insights Womens Health. 2018 Jan 8;11:1179562X17749608. doi: 10.1177/1179562X17749608. eCollection 2018.
A clinical study was conducted to evaluate the feasibility of using visible and near-infrared (NIR) spectroscopy as a potential noninvasive measure of genital skin health in premenopausal and postmenopausal women.
A total of 45 female subjects (aged 21-70 years), all of whom gave fully informed consent to participate, were enrolled in the study and assigned to 1 of 3 groups: 15 premenopausal (Pre-M), 15 postmenopausal receiving hormone replacement therapy (Post-M HRT), and 15 postmenopausal receiving no form of hormone replacement therapy (Post-M non-HRT). Spectral measurements were taken at the vaginal mucosa, and spectral data were evaluated for the erythema index (EI), hemoglobin index (HI), bilirubin/β-carotene, and melanin. The color index (CI; calculated as the ratio of absorbance at 480 nm/540 nm) was also determined. Results were compared with previously published results on biomarkers and physical characteristic of genital tissue measured on the same groups of women.
Spectral measurements from the Post-M Non-HRT subjects indicated a significant reduction in HI compared with the Pre-M group ( = .0003) and to the Post-M HRT group ( < .0001). Similarly, EI was reduced in the Post-M Non-HRT ( < .0001 and = .0041 for the Pre-M and Post-M HRT groups, respectively). In contrast, the Post-M Non-HRT subjects exhibited a significant increase in β-carotene compared with the Pre-M subjects ( = .0098). Bilirubin and melanin were not significantly affected. The Post-M Non-HRT group exhibited a significant increase in CI, indicating a shift away from the hemoglobin absorption region (510-620 nm wavelength) and toward the bilirubin/β-carotene absorption region (450-490 nm wavelength). This change was significant when compared with both the Pre-M group ( < .0001) and the Post-M HRT group ( = .0048). The changes in spectral measurements were consistent with previously reported changes in physical parameters (vaginal atrophy, increased pH, decreased skin temperature) and with decreased concentrations of the biomarkers histamine and histidine.
Hemodynamic spectral characteristics differ in postmenopausal vaginal tissue compared with tissue in premenopausal women, with decreased absorbance in the hemoglobin absorption region (510-620 nm wavelength) and an increased absorbance in the bilirubin/β-carotene absorption region (450-490 nm wavelength). A change in absorbance in the visible and NIR wavelengths is a promising, additional measure of genital skin health related to menopause and vulvovaginal atrophy.
开展了一项临床研究,以评估使用可见光谱和近红外(NIR)光谱作为绝经前和绝经后女性生殖器皮肤健康潜在非侵入性测量方法的可行性。
共有45名女性受试者(年龄21 - 70岁)参与本研究,所有受试者均已充分知情并同意参与,她们被分为3组中的1组:15名绝经前女性(绝经前组),15名接受激素替代疗法的绝经后女性(绝经后激素替代疗法组),以及15名未接受任何形式激素替代疗法的绝经后女性(绝经后非激素替代疗法组)。在阴道黏膜处进行光谱测量,并对光谱数据进行红斑指数(EI)、血红蛋白指数(HI)、胆红素/β - 胡萝卜素和黑色素评估。还测定了颜色指数(CI;计算为480nm/540nm处吸光度的比值)。将结果与之前发表的关于同一组女性生殖器组织生物标志物和物理特征的结果进行比较。
绝经后非激素替代疗法组受试者的光谱测量结果表明,与绝经前组相比,HI显著降低(P = 0.0003),与绝经后激素替代疗法组相比也显著降低(P < 0.0001)。同样,绝经后非激素替代疗法组的EI降低(与绝经前组相比P < 0.0001,与绝经后激素替代疗法组相比P = 0.0041)。相比之下,绝经后非激素替代疗法组受试者的β - 胡萝卜素与绝经前受试者相比显著增加(P = 0.0098)。胆红素和黑色素未受到显著影响。绝经后非激素替代疗法组的CI显著增加,表明从血红蛋白吸收区域(波长510 - 620nm)向胆红素/β - 胡萝卜素吸收区域(波长450 - 490nm)转变。与绝经前组(P < 0.0001)和绝经后激素替代疗法组(P = 0.0048)相比,这种变化均具有显著性。光谱测量的变化与之前报道的物理参数变化(阴道萎缩、pH值升高、皮肤温度降低)以及生物标志物组胺和组氨酸浓度降低一致。
与绝经前女性的组织相比,绝经后阴道组织的血流动力学光谱特征有所不同,血红蛋白吸收区域(波长510 - 620nm)的吸光度降低,胆红素/β - 胡萝卜素吸收区域(波长450 - 490nm)的吸光度增加。可见光谱和近红外波长吸光度的变化是一种有前景的、与绝经和外阴阴道萎缩相关的生殖器皮肤健康的额外测量方法。